Lydia A. Bazzano, MD, PhD; Jiang He, MD, PhD; Paul Muntner, PhD; Suma Vupputuri, PhD; Paul K. Whelton, MD, MSc
Grant Support: In part by grant RO1 HL60300 from the National Heart, Lung, and Blood Institute of the National Institutes of Health.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Jiang He, MD, PhD, Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1430 Tulane Avenue SL18, New Orleans, LA 70112.
Current Author Addresses: Dr. Bazzano: Department of Internal Medicine, Beth Israel Deaconess Hospital, 330 Brookline Avenue, Deaconess Building 300, Boston, MA 02215.
Drs. He, Muntner, and Whelton: Tulane University School of Public Health and Tropical Medicine, 1430 Tulane Avenue SL18, New Orleans, LA 70112.
Dr. Vupputuri: National Institute of Environmental Health Sciences, 111 Alexander Drive, Research Triangle Park, NC 27709.
Author Contributions: Conception and design: L.A. Bazzano, J. He.
Analysis and interpretation of the data: L.A. Bazzano, J. He, P. Muntner.
Drafting of the article: L.A. Bazzano, J. He.
Critical revision of the article for important intellectual content: L.A. Bazzano, J. He, P. Muntner, S. Vupputuri, P.K. Whelton.
Final approval of the article: L.A. Bazzano, J. He, P. Muntner, S. Vupputuri, P.K. Whelton.
Statistical expertise: L.A. Bazzano, J. He, P. Muntner.
Obtaining of funding: J. He.
Administrative, technical, or logistic support: J. He.
Few studies have examined the relationship between cigarette smoking and novel risk factors for cardiovascular disease in a general population or have included a biochemical marker of current smoking.
To examine the relationship between cigarette smoking and serum C-reactive protein, fibrinogen, and homocysteine levels.
The U.S. general population.
4187 current smokers, 4791 former smokers, and 8375 never-smokers 18 years of age or older who participated in the Third National Health and Nutrition Examination Survey conducted between 1988 and 1994.
Serum C-reactive protein levels were categorized as detectable (2.2 to 9.9 mg/L) or clinically elevated ( 10 mg/L), and fibrinogen and homocysteine levels were defined as elevated if in the 85th percentile or greater (11.1 mol/L and 12.7 mmol/L, respectively).
After adjustment for traditional cardiovascular disease risk factors, cigarette smoking was related to elevated levels of C-reactive protein, fibrinogen, and homocysteine. Compared with never smoking cigarettes, self-reported current cigarette smoking was associated with a C-reactive protein level in the detectable (odds ratio, 1.66 [95% CI, 1.40 to 1.97]; P < 0.001) or clinically elevated (odds ratio, 1.98 [CI, 1.57 to 2.51]; P < 0.001) ranges, with elevated levels of fibrinogen (odds ratio, 2.15 [CI, 1.65 to 2.80]; P < 0.001) and homocysteine (odds ratio, 2.10 [CI, 1.62 to 2.74]; P < 0.001). There were positive and significant doseresponse relationships between measures of cigarette smoking (cigarettes per day, pack-years, and serum cotinine levels) and elevated levels of novel risk factors.
These findings suggest that inflammation and hyperhomocysteinemia may be important mechanisms by which smoking promotes atherosclerotic disease.
Bazzano LA, He J, Muntner P, et al. Relationship between Cigarette Smoking and Novel Risk Factors for Cardiovascular Disease in the United States. Ann Intern Med. 2003;138:891–897. doi: 10.7326/0003-4819-138-11-200306030-00010
Download citation file:
Published: Ann Intern Med. 2003;138(11):891-897.
Cardiology, Coronary Risk Factors, Prevention/Screening, Smoking, Tobacco, Alcohol, and Other Substance Abuse.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use